Ionis Pharmaceuticals Inc (NAS:IONS)
$ 38.421 -0.379 (-0.98%) Market Cap: 5.61 Bil Enterprise Value: 4.90 Bil PE Ratio: 0 PB Ratio: 18.93 GF Score: 70/100

Ionis Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 12, 2021 / 02:15PM GMT
Release Date Price: $40.87 (-3.52%)
Chad Jason Messer
Needham & Company, LLC, Research Division - Senior Analyst

Great. Hello, everyone. Thanks for joining us at the Needham & Company Virtual Healthcare Conference. My name is Chad Messer. I'm one of the senior biotech analysts here at Needham, and it is my pleasure today to be joined by Patrick Swayze, Head of research at Ionis Pharmaceuticals, to discuss -- I don't think we'll hit them all, but many of the exciting programs that are going on at Ionis.

So if Patrick, if I could just -- Eric, excuse me, if I could just jump in...

Eric E. Swayze
Ionis Pharmaceuticals, Inc. - EVP of Research

I'm very excited to be messed up -- mixed up with the guy who did Dirty Dancing. So...

Chad Jason Messer
Needham & Company, LLC, Research Division - Senior Analyst

I am of that generation where the mental crossover is almost inevitable.

Questions & Answers

Chad Jason Messer
Needham & Company, LLC, Research Division - Senior Analyst

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot